Investigation of the efficiency and safety of tilmicosin phosphate in treating experimental mycoplasmal infections in pigs
In order to evaluate the in vivo therapeutic effect of oral administration of tilmicosin phosphate on mycoplasmal pneumonia
in swine and its safety for the infected swine, the model of mycoplasmal pneumonia disease in swine was established by artificial
infection, and indices such as efficiency, cure rate, death rate, the score of lung lesion, and the routine blood tests, blood biochemistry,
and routine urine tests of tested swine were determined. The results showed that all of the dosage groups of 100 mg/L, 80 mg/L, 60 mg/L
of 10% tilmicosin phosphate soluble powder demonstrated distinct therapeutic effects on mycoplasmal pneumonia in pigs, significantly
reducing the scores of lung lesions in diseased pigs, and that the treatment effect of 60-80 mg/L tilmicosin phosphate soluble powder
was equivalent to that of 10% tilmicosin soluble powder. Administration of 10% tilmicosin phosphate soluble powder improved the
weight gain of the diseased swine. Treatment of infected pigs with 60?100 mg/L of 10% tilmicosin phosphate soluble powder did
not seem to influence the routine blood tests, biochemical index, and routine urine tests, and is therefore safe for diseased swine. In
conclusion, administration of 10% tilmicosin phosphate soluble powder is effective and safe to treat artificially infected swine with
mycoplasmal pneumonia.
___
- Holst S, Yeske P, Pieters M. Elimination of
Mycoplasma
hyopneumoniae
from breed-to-wean farms: a review of current
protocols with emphasis on herd closure and medication. J
Swine Health Prod 2015; 23: 321-330.
- Blanchard B, Vena M, Cavalier A, Le Lannic J, Gouranton
J, Kobisch M. Electron microscopic observation of the
respiratory tract of SPF piglets inoculated with
Mycoplasma
hyopneumoniae
. Vet Microbiol 1992; 30: 329-341.
- Sibila M, Pieters M, Molitor T, Maes D, Haesebrouck F, Segales
J. Current perspectives on the diagnosis and epidemiology of
Mycoplasma hyopneumoniae
infection. Vet J 2009; 181: 221-
231.
- Garcia-Morante B, Segales J, Fraile L, Perez de Rozas A, Maiti
H, Coll T, Sibila M. Assessment of
Mycoplasma hyopneumoniae
induced pneumonia using different lung lesion scoring systems:
a comparative review. J Comp Pathol 2015; 154: 125-134.
- Michiels A, Piepers S, Ulens T, Van Ransbeeck N, Del Pozo
Sacristan R, Sierens A,Maes D. Impact of particulate matter
and ammonia on average daily weight gain, mortality and lung
lesions in pigs. Prev Vet Med 2015; 121: 99-107.
- Dubosson C, Conzelmann C, Miserez R, Boerlin P, Frey J,
Zimmermann W, Kuhnert P. Development of two real-time
PCR assays for the detection of
Mycoplasma hyopneumoniae
in
clinical samples. Vet Microbiol 2005; 102: 55-65.
- Strait E, Madsen M, Minion F, Christopher-Hennings J,
Dammen M, Jones K, Thacker E. Real-time PCR assays
to address genetic diversity among strains of
Mycoplasma
hyopneumoniae
. J Clin Microbiol 2008; 46: 2491-2498.
- Maes D, Sibila M, Kuhnert P, Segales J, Haesebrouck F, Pieters
M. Update on
Mycoplasma hyopneumoniae
infections in pigs:
knowledge gaps for improved disease control. Transbound
Emerg Dis 2017; 23: doi: 10.1111/tbed.12677.
- Zhang P, Hao H, Li J, Ahmad I, Cheng G, Chen D, Tao Y, Huang
L, Wang Y, Dai M. The epidemiologic and pharmacodynamic
cutoff values of tilmicosin against
Haemophilus parasuis
. Front
Microbiol 2016; 7: 385.
- Kang S, Li Z, Yin Z, Jia R, Song X, Li L, Chen Z, Peng L, Qu J,
Hu Z et al. The antibacterial mechanism of berberine against
Actinobacillus pleuropneumoniae
. Nat Prod Res 2015; 29: 2203-
2206.
- Frank GH, Briggs RE, Loan RW, Purdy CW, Zehr ES. Effects
of tilmicosin treatment on
Pasteurella haemolytica
organisms
in nasal secretion specimens of calves with respiratory tract
disease. Am J Vet Res 2000; 61: 525-529.
- Naccari F, Giofrè F, Pellegrino M, Calò M, Licata P, Carli S.
Effectiveness and kinetic behaviour of tilmicosin in the
treatment of respiratory infections in sheep. Vet Rec 2001; 148:
773-776.
- Zhang L, Zhao L, Liu Y, Liu J, Li X. Pharmacokinetics of
tilmicosin in healthy pigs and in pigs experimentally infected
with
Haemophilus parasuis
. J Vet Sci 2017; 18: 431-437.
- Tavio M, Poveda C, Assuncao P, Ramirez A, Poveda J. In vitro
activity of tylvalosin against Spanish field strains of
Mycoplasma
hyopneumoniae
. Vet Rec 2014; 175: 539.
- Fittipaldi N, Klopfenstein C, Gottschalk M, Broes A, Paradis
MA, Dick CP. Assessment of the efficacy of tilmicosin
phosphate to eliminate
Actinobaclillus pleuropneumoniae
from
carrier pigs. Can J Vet Res 2005; 69: 146-150.
- Lindecrona RH, Friis C, Nielsen JP. Pharmacokinetics and
penetration of danofloxacin into the gastrointestinal tract in
healthy and in
Salmonella typhimurium
infected pigs. Res Vet
Sci 2000; 68: 211-216.
- Sang K, Hao H, Huang L, Wang X, Yuan Z. Pharmacokinetic–
pharmacodynamic modeling of enrofloxacin against
Escherichia coli
in broilers. Front Vet Sci 2015; 2: 80.
- van Miert A. Influence of febrile disease on the pharmacokinetics
of veterinary drugs. Annal Vet Res 1990; 21: 11S-28S.
- Shao GQ, Liu MJ, Sun PY, Wang JC, Du G, Zhou Y, Liu D.
The establishment of an experimental swine model of swine
mycoplasma pneumonia. Journal of Microbes and Infection
2007; 2: 215-218.
- Otake S, Dee S, Corzo C, Oliveira S, Deen J. Long-distance
airborne transport of infectious PRRSV and
Mycoplasma
hyopneumoniae
from a swine population infected with multiple
viral variants. Vet Microbiol 2010; 145: 198-208.
- Kick AR, Tompkins MB, Hammer JM, Routh PA, Almond
GW. Evaluation of peripheral lymphocytes after weaning and
vaccination for
Mycoplasma hyopneumoniae
. Res Vet Sci 2011;
91: 68-72.
- Del Pozo Sacristan R. Treatment and control of
Mycoplasma
hyopneumoniae
infections. PhD, Ghent University, Ghent,
Belgium 2014; 189.
- Scorneaux B, Shryock TR. Intracellular accumulation,
subcellular distribution and efflux of tilmicosin in swine
phagocytes. J Vet Pharmacol Ther 1998; 21: 257268.
- Paradis MA, Vessie GH, Merrill JK, Dick CP, Moore C,
Charbonneau G, Gottschalk M, MacInnes JI, Higgins R, Mittal
KR, Girard C, Aramini JJ, Wilson JB. Efficacy of tilmicosin
in the control of experimentally induced
Actinobacillus
pleuropneumoniae
infection in swine. Can J Vet Res 2004; 68:
7-11.
- Moore GM, Mowrey DH, Tonkinson LV, Lechtenberg KF,
Schneider JH. Efficacy dose determination study of tilmicosin
phosphate in feed for control of pneumonia caused by
Actinobacillus pleuropneumoniae
in swine. Am J Vet Res 1996;
57: 220-223.
- Khan AT, Zafar F. Hematological study in response of varying
doses of estrogen in broiler chicken. Int J Poultry Sci 2005; 10:
748-751.
- Scorneaux B, Shryock TR. Intracellular accumulation,
subcellular distribution, and efflux of tilmicosin in bovine
mammary, blood, and lung cells. J Dairy Sci 1999; 82: 1202-
1212.
- Smith CM, Reynard AM. Textbook of Pharmacology. London:
W. B. Saunders, 1992.
- Elsayed M, Elkomy A, Aboubakr M, Morad M. Tissue residues,
hematological and biochemical effects of tilmicosin in broiler
chicken. Vet Med Int 2014; doi: 10.1155/2014/502872.
- Shiwa T, Nishimura M, Kato M. The effectiveness of the semi-
quantitative assessment of microalbuminuria using routine
urine dipstick screening in patients with diabetes. Intern Med
2018; 57: 503-506.